Vascular nitric oxide, sex hormone replacement, and fish oil may help to prevent Alzheimer's disease by suppressing synthesis of acute-phase cytokines

Medical Hypotheses

Volumn 53, Issue 5, 1999, Pages 369-374

  McCarty, M F ^a  

^a Nutrition 21   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESTROGEN RECEPTOR; FISH OIL; GAMMA LINOLENIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; SEX HORMONE; TESTOSTERONE;

ACUTE PHASE RESPONSE; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CYTOKINE PRODUCTION; ESTROGEN DEFICIENCY; GLIA CELL; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; JAPAN; NEUROPROTECTION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0032730094     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1998.0783     Document Type: Article

References (85)

1. Abraham C. R., Selkoe D. J., Potter H. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 42:1988;487-501.
2. McGeer P. L., Klegeris A., Walker D. G. Pathological proteins in senile plaques. Tohoku J Exp Med. 174:1994;269-277.
3. Mrak R. E., Sheng J. G., Griffin W. S. T. Glial cytokines in Alzheimer's disease. Human Pathol. 26:1995;816-823.
4. H?ll M., Berger M., Volk B., Bauer J. Occurrence of interleukin-6 in cortical plaques of Alzheime's disease patients may precede transformation of diffuse into neuritic plaques. Ann NY Acad Sci. 777:1996;205-212.
5. Hüll M., Fiebich B. L., Lieb K. Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options. Neurobiol Aging. 17:1996;795-800.
6. Heyser C. J., Masliah E., Samimi A. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci. 94:1997;1500-1505.
7. Vandenabeele P., Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain. Immunol Today. 12:1991;217-219.
8. McGeer P. L., McGeer E. G. Anti-inflammatory drugs in the fight against Alzheimer's disease. Ann NY Acad Sci. 777:1996;213-220.
9. Ganter U., Strauss S., Jonas U. Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. FEBS Lett. 282:1991;127-131.
10. Araujo D. M., Cotman C. W. β-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res. 569:1992;141-145.
11. Del Bo R., Angeretti N., Lucca E. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and b-amyloid production in cultures. Neurosci Lett. 188:1995;70-74.
12. Lieb K., Fiebich B. L., Hüll M. Potent inhibition of interleukin-6 expression in a human astrocytoma cell line by tenidap. Cell Tissue Res. 288:1997;251-257.
13. Rich J. B., Rasmusson D. X., Folstein F. M. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology. 45:1995;51-55.
14. Breitner J. C. S. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Ann Rev Med. 47:1996;401-411.
15. Stewart W. F., Kawas C., Corrada M., Metter E. J. Risk of Alzheimer's disease and duration of NSAID use. Neurology. 48:1997;626-632.
16. Rogers J. S., Kirby L. C., Hempelman S. R. Clinical trial of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
17. Beckman J. S., Beckman T. W., Chen J. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci. 87:1990;1620-1624.
18. Hogg N., Darley-Usmar V. M., Wilson M. T., Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J. 281:1992;419-424.
19. Arndt H., Russell J. B., Kurose I. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology. 105:1993;675-680.
20. De Caterina R., Libby P., Peng H. B. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 96:1995;60-68.
21. Clancy R. M., Leszczynska-Piziak J., Abramson S. B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest. 90:1992;1116-1121.
22. Heller R., Bussolino F., Ghigo D. Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells. Biochem Pharm. 44:1992;223-229.
23. Davenpeck K. L., Gauthier T. W., Lefer A. M. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology. 107:1994;1050-1058.
24. Zeiher A. M., Fisslthaler B., Schray-Utz B., Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res. 76:1995;980-986.
25. Peng H. B., Libby P., Liao J. K. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J Biol Chem. 270:1995;14214-14219.
26. Liou H. C., Baltimore D. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr Opin Cell Biol. 5:1993;477-487.
27. Shimizu H., Mitomo K., Watanabe T. Involvement of a NF-κB like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol. 10:1990;561-568.
28. Liebermann T., Baltimore D. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol Cell Biol. 10:1990;2327-2334.
29. Matsusaka T., Fujikawa K., Nishio Y. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci. 90:1993;10193-10197.
30. Ray A., Prefontaine K. E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci. 91:1994;752-756.
31. Persoons J. H. A., Schornagel K., Tilders F. F. H. Alveolar macrophages autoregulate IL-1 and IL-6 production by endogenous nitric oxide. Am J Respir Cell Mol Biol. 14:1996;272-278.
32. McCarty M. F. Vascular nitric oxide may lessen Alzheimer's risk. Med Hypotheses. 51:1998;465-476.
33. Barger S. W., Fiscus R. R., Ruth P. Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J Neurochem. 64:1995;2087-2096.
34. Barger S. W., Mattson M. P. The secreted form of the Alzheimer's β-amyloid precursor protein stimulates a membrane-associated guanylate cyclase. Biochem J. 311:1995;45-47.
35. Henderson B. E., Paganini-Hill A., Emanuel C. K. Estrogen replacement therapy in older women. Arch Neurol. 51:1994;896-900.
36. Tang M. X., Jacobs D., Stern Y. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
37. Razay G., Wilcock G. K. Hyperinsulinaemia and Alzheimer's disease. Age Ageing. 23:1994;396-399.
38. Leibson C. L., Rocca W. A., Hanson V. A. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol. 145:1997;301-308.
39. Hofman A., Ott A., Breteler M. M. B. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 349:1997;151-154.
40. Launer L. J., Masaki K., Petrovitch H. The association between midlife blood pressure levels and late-life cognitive function. J Am Med Assoc. 274:1995;1846-1851.
41. Skoog I., Lernfelt B., Landahl S. 15-year longitudinal study of blood pressure and dementia. Lancet. 347:1996;1141-1145.
42. Hayashi T., Fukuto J. M., Ignarro L. J., Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci. 89:1992;11259-11263.
43. Weiner C. P., Lizasoain I., Baylis S. A. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci. 91:1994;5212-5216.
44. Kharitonov S. A., Logan-Sinclair R. B., Busset C. M., Shinebourne E. A. Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J. 72:1997;243-245.
45. Hishikawa K., Nakaki T., Marumo T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 360:1995;291-293.
46. Girasole G., Jilka R. L., Passeri G. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro. A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 89:1992;883-891.
47. Jilka R. L., Hangoc G., Griasole G. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 257:1992;88-91.
48. Pottratz S. T., Bellido T., Mocharla H. 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest. 93:1994;944-950.
49. Ray A., Prefontaine K. E., Ray P. Down-regulation of interleukin-6 gene expression by 17β-estradiol in the absence of high af1/2nity DNA binding by the estrogen receptor. J Biol Chem. 269:1994;12940-12946.
50. Stein B., Yang M. X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ Mol Cell Biol. 15:1995;4971-4979.
51. Kassem M., Harris S. A., Spelsberg T. C., Riggs B. L. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res. 11:1996;193-199.
52. Ray P., Ghosh S. K., Zhang D. H., Ray A. Repression of interleukin-6 gene expression by 17β-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-κB by the estrogen receptor. FEBS Lett. 409:1997;79-85.
53. Jung-Testas I., Renoir M., Bugnard H. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J Steroid Biochem Molec Biol. 41:1992;621-631.
54. Langub M. C. Jr, Watson R. E. Jr. Estrogen receptor-immunoreactive glia, endothelia, and ependyma in guinea pig preoptic area and median eminence: electron microscopy. Endocrinology. 130:1992;364-372.
55. Santagati S., Melcangi R. C., Celotti F. Estrogen receptor is expressed in different types of glial cells in culture. J Neurochem. 63:1994;2058-2064.
56. Wakley G. K., Schutte H. D. Jr, Hannon K. S., Turner R. T. Androgen treatment prevents loss of cancellous bone in the orchidectomized rat. J Bone Miner Res. 6:1991;325-330.
57. Bellido T., Jilka R. L., Boyce B. F. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest. 95:1995;2886-2895.
58. Keller E. T., Chang C., Ershler W. B. Inhibition of NFκB activity through maintenance of IκBα levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem. 271:1996;26267-26275.
59. Puy L., MacLusky N. J., Becker L. Immunocytochemical detection of androgen receptor in human temporal cortex: characterization and application of polyclonal androgen receptor antibodies in frozen and paraffin-embedded tissues. J Steroid Biochem Molec Biol. 55:1995;197-209.
60. Verzat C., Courriere P., Hollande E. Heterotransplantation of a human oligoastrocytoma into nude mice: difference in tumour growth between males and females. Neuropathol Appl Neurobiol. 18:1992;37-51.
61. Lin S. C., Yamate T., Taguchi Y. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J Clin Invest. 100:1997;1980-1990.
62. Endres S., Ghorbani R., Kelly V. E. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 320:1989;265-271.
63. Caughey G. E., Mantzioris E., Gibson R. A. The effect on human tumor necrosis factor a and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or 1/2sh oil. Am J Clin Nutr. 63:1996;116-122.
64. Robinson D. R., Urakaze M., Huang R. Dietary marine lipids suppress continuous expression of interleukin-1β gene transcription. Lipids. 31:1996;S23-S31.
65. Rola-Pleszczynski M., Lemaire I. Leukotriens augment interleukin 1 production by human monocyte. J Immunol. 135:1985;3958-3961.
66. 4-induced interleukin-1β in synovial cells from patients with rheumatoid arthritis. Scand J Rheumatol. 23:1994;148-150.
67. Lee T. H., Hoover R. L., Williams J. D. Effect of dietary enrichment with eicosapetaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med. 312:1985;1217-1224.
68. Sperling R. I. Effects of dietary 1/2sh oil on leukocyte leukotriene and PAF generation and on neutrophil chemotaxis. Simopoulos A. P., Kifer R. R., Martin R. E., Barlow S. M. Health Effects of w3 Polyunsaturated Fatty Acids in Seafoods. 1991;391-400 Karger, Basel.
69. Peers R. J. Alzheimer's disease and omega-3 fatty acids: hypothesis. Med J Aust. 153:1990;563-564.
70. Breteler M. M. B., Claus J. J., van Duijn C. M. Epidemiology of Alzheimer's disease. Epidemiologic Rev. 14:1992;59-82.
71. Ishino H., Seno H., Inagaki T. Relative frequencies of dementia of the Alzheimer type and vascular dementia in Japanese nursing homes. Jpn J Psychiatry Neurol. 44:1990;551-556.
72. Jorm A. F. Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias. Eur Arch Psychiatry Clin Neurosci. 240:1991;218-222.
73. Graves A. B., Larson E. B., White L. R. Opportunities and challenges in international collaborative epidemiologic research of dementia and its subtypes: studies between Japan and the US. Int Psychogeriatr. 6:1994;209-223.
74. Shimokawa H., Lam J. Y. T., Chesebro J. H. Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation. 76:1987;898-905.
75. Boulanger C., Schini V. B., Hendrickson H., Vanhoutte P. M. Chronic exposure of cultured endothelial cells to eicosapentaenoic acid potentiates the release of endothelium-derived relaxing factors(s). Br J Pharmacol. 99:1990;176-180.
76. McVeigh G. E., Brennan G. M., Johnston G. D. Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 36:1993;33-38.
77. Vanderhoek J. Y., Bryant R. W., Bailey J. M. Regulation of leukocyte and platelet lipoxygenases by hydroxyeicosanoids. Biochem Pharm. 31:1982;3463-3467.
78. Miller C. C., Tang W., Ziboh V. A., Fletcher M. P. Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolities. J Invest Dermatol. 96:1991;98-103.
79. 4. Am J Clin Nutr. 55:1992;39-45.
80. Watson J., Byars M. L., McGill P., Kelman A. W. Cytokine and prostaglandin production by monocytes of volunteers and rheumatoid arthritis patients treated with dietary supplements of blackcurrant seed oil. Br J Rheumatol. 32:1993;1055-1058.
81. Purasiri P., Murray A., Richardson S. Modulation of cytokine production in vivo by dietary essential fatty acids in patients with colorectal cancer. Clin Sci. 87:1994;711-717.
82. Sano M., Ernesto C., Thomas R. G. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 336:1997;1216-1222.
83. Birge S. J. The role of estrogen in the treatment of Alzheimer's disease. Neurology. 48:1997;S36-S41.
84. McCarty M. F. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses. 52:1998;465-478.
85. Marin P. Testosterone and regional fat distribution. Obes Res. 3:1995;609S-612S.